Form 4: Rigel Pharmaceuticals CEO Raul Rodriguez Sells Shares to Cover Tax Obligations

Rigel Pharmaceuticals CEO Raul Rodriguez sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On February 4, 2025, Raul Rodriguez, CEO and President of Rigel Pharmaceuticals, sold 4,952 shares of common stock at a price of $20.921 per share.
• On February 5, 2025, Rodriguez sold an additional 4,400 shares of common stock at a price of $21.926 per share.
• These sales were executed to cover tax withholding obligations due upon the vesting of restricted stock units and do not represent discretionary trades by Rodriguez.
• Following these transactions, Rodriguez directly owns 239,454 shares of Rigel Pharmaceuticals common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the stock sales are related to tax obligations and not necessarily indicative of the executive's view on the company's performance.

Management Comments

• The sales to cover were automatically effected to satisfy tax withholding obligations and do not represent a discretionary trade by the Reporting Person.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market, but the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates

Keywords

Rigel Pharmaceuticals, Raul Rodriguez, stock sale, Form 4, tax withholding, restricted stock units, beneficial ownership